Biotech

All Articles

Analysts go into Avidity's DMD succeed, disclosing nuances in information

.Avidity Biosciences satisfied clients along with stage 1/2 data in Duchenne muscular dystrophy (DMD...

Actinogen's cortisol blocker neglects phase 2 clinical depression research

.Actinogen Medical's cortisol blocker has actually missed out on the main endpoint of a phase 2 rese...

Bivictrix determines going private only means to take ADC into facility

.Antibody-drug conjugates (ADCs) have actually been at the center of several a billion-dollar biobuc...

TPG bests up funds to $580M for investments all over lifestyle scientific researches

.Possession supervisor TPG, which has assisted biotechs including Sionna Rehabs and also Santa Clam ...

Merck stops stage 3 TIGIT trial in bronchi cancer cells for impossibility

.Merck &amp Co.'s TIGIT program has gone through yet another misfortune. Months after shuttering a s...

After a challenging year, Exscientia folds into Recursion

.After a year specified by pipe cuts, the departure of its own chief executive officer and also disc...

Cullinan, after $25M package, restore bispecific to Harbour

.Cullinan Therapeutics was actually excited sufficient with Port BioMed's bispecific immune system a...

A closer look at Fierce Biotech's Ferocious 15

.Within this week's incident of "The Top Pipe," our company are actually diving into Strong Biotech'...

Lilly faces stage 2 breakdown of tau-targeting med

.The confetti is actually still flying from Eli Lilly's party celebrating the commendation of Alzhei...

Biogen CMO Maha Radhakrishnan signs up with Sofinnova-- Chutes &amp Ladders

.Invite to recently's Chutes &amp Ladders, our summary of significant leadership hirings, firings as...